BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Nymox Pharmaceutical Corporation 

175 Bouchard, Suite 100

Dorval  Quebec  H9S 1B1  Canada
Phone: 514-636-3122 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Nymox Pharmaceutical (NYMX) Reports 2013 Financial Results 3/17/2014 8:47:43 AM    More...
Nymox Pharmaceutical (NYMX) Announces Appointment Of Andre Monette 2/6/2014 9:51:08 AM    More...
Nymox Pharmaceutical (NYMX) Closes Recruitment For NX-1207 Phase 2 Prostate Cancer Trial 1/14/2014 9:28:20 AM    More...
Incyte Corporation (INCY) Closes Recruitment For NX-1207 Phase 2 Prostate Cancer Trial 1/13/2014 7:42:43 AM    More...
Nymox Pharmaceutical (NYMX) Provides Update On NX-1207 Phase 3 BPH And Phase 2 Prostate Cancer Clinical Trial Activities 1/9/2014 7:21:23 PM    More...
Nymox Pharmaceutical (NYMX) Reports Update And Positive Safety Data For Phase 3 NX02-0022 Reinjection Study Of NX-1207 For BPH 11/11/2013 11:38:44 AM    More...
Press Release Issued Under the Early Warning System/Sale of Shares of Nymox Pharmaceutical (NYMX) 10/4/2013 9:32:56 AM    More...
Nymox Pharmaceutical (NYMX) Prostate Cancer Drug Treatment Trial Nears Completion 9/26/2013 9:37:36 AM    More...
Nymox Pharmaceutical (NYMX) Reports Positive Results of Safety Monitoring Committee Review of NX02-0018 Phase 3 Trial 8/22/2013 9:56:23 AM    More...
Nymox Pharmaceutical (NYMX) Reports Positive Safety Monitoring Committee Results for Pivotal NX02-0017 Phase 3 Trial 7/12/2013 9:26:08 AM    More...
12345678910...